Xenon Pharmaceuticals voluntarily paused new enrollment in its major depressive disorder and bipolar depression trials due to safety events consistent with the drug azetukalner's known profile. These events had not appeared in earlier phase II trials. The pause, made with the safety monitoring board's advice, is expected to be temporary and does not affect ongoing epilepsy studies. Current trial participants will continue in the studies.
Xenon Pharmaceuticals' recent trial enrollment pause is presented here with related Health sector market data from Pluang. Of 92 priced Health-sector US stocks tradable on Pluang, 22 rose and 70 fell today. Notable movers include GSK at USD 50.08 with a 1-day change of -1.92%, Vertex Pharmaceuticals at USD 506.54 with a 1-day change of -1.86%, and ACADIA Pharmaceuticals at USD 26.95 with a 1-day change of -1.82%. This data is as of Sep 18, 2026 23:02 WIB.
Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...
Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...
Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...
HYPE token surged 10.5% to $91.20, reaching a new all-time high of $92.56 after Hyperliquid launched manual borrowing of USDC and USDT using HYPE and Bitcoin as collateral. The platform offers a 65% loan-to-value ratio for HYPE, higher than Bitcoin's...
CleanTech Vanadium Mining Corp. has engaged Mercator Geological Services to prepare an independent technical report on its Campbell-Crotser fluorspar project in Kentucky, following National Instrument 43-101 standards. The report will detail geology,...
